Skip to main content

Table 1 Demographic characteristics and comorbidity profile for women diagnosed with HCV in BC in 2019, stratified by care cascade stages

From: Women in the 2019 hepatitis C cascade of care: findings from the British Columbia Hepatitis Testers cohort study

Variable Antibody Diagnosed HCV RNA Tested HCV RNA Positive HCV Genotyped HCV Treatment Initiated SVR Achieved/Unknown SVR Achieved
n % n % n % n % n % n % n %
Total 19,522 100 16,797 100 11,075 100 10,007 100 6755 100 5683 100 4932 100
Birth Cohort
< 1945 974 4.99 786 4.68 570 5.15 505 5.05 322 4.77 270 4.75 228 4.62
1945–1964 10,046 51.46 8701 51.8 6028 54.43 5620 56.16 4288 63.48 3680 64.75 3279 66.48
1965–1974 4162 21.32 3492 20.79 2210 19.95 1975 19.74 1197 17.72 986 17.35 814 16.5
> 1974 4340 22.23 3818 22.73 2267 20.47 1907 19.06 948 14.03 747 13.14 611 12.39
Ethnicity
East Asian 1045 5.35 864 5.14 542 4.89 496 4.96 379 5.61 331 5.82 302 6.12
South Asian 872 4.47 803 4.78 549 4.96 521 5.21 395 5.85 338 5.95 263 5.33
Other BC Residents 17,605 90.2 15,130 90.1 9984 90.15 8990 89.84 5981 88.54 5014 88.22 4367 88.55
Material Deprivation Quintile
Q1 (most privileged) 2622 13.43 2294 13.66 1514 13.67 1390 13.89 953 14.11 797 14.02 698 14.15
Q2 2985 15.29 2602 15.49 1731 15.63 1597 15.96 1140 16.88 958 16.86 844 17.11
Q3 3557 18.22 3085 18.37 2058 18.58 1859 18.58 1337 19.79 1135 19.97 995 20.17
Q4 4407 22.57 3778 22.49 2511 22.67 2289 22.87 1569 23.23 1351 23.77 1155 23.42
Q5 (most deprived) 5391 27.61 4669 27.8 3033 27.39 2689 26.87 1662 24.6 1361 23.95 1168 23.68
Unknown 560 2.87 369 2.2 228 2.06 183 1.83 94 1.39 81 1.43 72 1.46
Social Deprivation Quintile
Q1 (most privileged) 2351 12.04 369 2.2 1369 12.36 1258 12.57 923 13.66 766 13.48 642 13.02
Q2 2337 11.97 2053 12.22 1320 11.92 1209 12.08 878 13 768 13.51 648 13.14
Q3 2992 15.33 2018 12.01 1749 15.79 1591 15.9 1113 16.48 943 16.59 838 16.99
Q4 4332 22.19 2599 15.47 2392 21.6 2175 21.73 1522 22.53 1269 22.33 1137 23.05
Q5 (most deprived) 6950 35.60 3717 22.13 4017 36.27 3591 35.88 2225 32.94 1856 32.66 1595 32.34
Unknown 560 2.87 6041 35.96 228 2.06 183 1.83 94 1.39 81 1.43 72 1.46
Urbanicity
Rural 2525 12.93 2222 13.23 1484 13.4 47 0.47 983 14.55 845 14.87 747 15.15
Urban 16683 85.46 14436 85.94 9511 85.88 1379 13.78 5766 85.36 4835 85.08 4182 84.79
Unknown 314 1.61 139 0.83 80 0.72 8581 85.75 6 0.09 3 0.05 3 0.06
History of Injection Drug Use
Yes 7265 37.21 6497 38.68 4210 38.01 3741 37.38 2122 31.41 1698 29.88 1412 28.63
No 12257 62.79 10300 61.32 6865 61.99 6266 62.62 4633 68.59 3985 70.12 3520 71.37
History of Opioid use*
Yes 4556 62.71 4154 63.94 2654 63.04 2375 63.49 1294 60.98 1021 60.13 843 59.7
No 2709 37.29 2343 3606 1556 36.96 1366 36.51 828 39.02 677 39.87 569 40.3
History of stimulant use*       
Yes 4327 59.56 3938 60.61 2513 59.69 2238 59.82 1202 56.64 945 55.65 768 54.39
No 2938 40.44 2559 39.39 1697 40.31 1503 40.18 920 43.36 753 44.35 644 45.61
Problematic Alcohol Use
Yes 4952 25.37 4442 26.45 2797 25.26 2534 25.32 1549 22.93 1284 22.59 1084 21.98
No/Unknown 14570 74.63 12355 73.55 8278 74.74 7473 74.68 5206 77.07 4399 77.41 3848 78.02
Major Mental Health Diagnosis
Yes 7,379 37.8 6646 39.57 4331 39.11 3945 39.42 2572 38.08 2115 37.22 1804 36.58
No/Unknown 12,143 62.2 10,151 60.43 6744 60.89 6062 60.58 4183 61.92 3568 62.78 3128 63.42
HBV Coinfection
Yes 905 4.64 904 5.38 579 5.23 538 5.38 366 5.42 575 5.42 487 9.87
No/Unknown 18,617 95.36 15,893 94.62 10,496 94.77 9469 94.62 6389 94.58 5108 94.58 4445 90.13
HIV/AIDS Coinfection
Yes 565 2.89 904 5.38 475 4.29 448 4.48 281 4.16 233 4.1 204 4.14
No/Unknown 18,957 97.11 16,096 95.82 10,600 95.72 9559 95.53 6474 95.84 5450 95.9 4728 95.86
Cirrhosis
Yes 807 4.13 752 4.48 608 5.49 581 5.81 493 7.3 418 7.36 379 7.68
No/Unknown 18,715 95.87 16,045 95.52 10,467 94.51 9426 94.19 6262 92.7 5265 92.64 4553 92.32
Decompensated Cirrhosis
Yes 468 2.4 423 2.52 331 2.99 308 3.08 245 3.63 205 3.61 187 3.79
No/Unknown 19,054 97.6 16,374 97.48 10,744 97.01 9699 96.92 6510 96.37 5478 96.39 4745 96.21
  1. *Includes only women with a history of injection drug use